• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在新西兰一个有资金支持和积极管理的护理体系中,接受体外受精的夫妇的辍学率和累计生育结局。

Dropout rate and cumulative birth outcomes in couples undergoing in vitro fertilization within a funded and actively managed system of care in New Zealand.

机构信息

Fertility Associates, Auckland and Hamilton, New Zealand.

Fertility Associates, Auckland and Hamilton, New Zealand.

出版信息

Fertil Steril. 2021 Jul;116(1):114-122. doi: 10.1016/j.fertnstert.2021.01.041. Epub 2021 Mar 19.

DOI:10.1016/j.fertnstert.2021.01.041
PMID:33752879
Abstract

OBJECTIVE

To determine the dropout rate between the first and second in vitro fertilization (IVF) cycles in a controlled population derived from a funded and actively managed system of care in New Zealand, including the reason for dropout and associated cumulative live birth rate.

DESIGN

Retrospective cohort.

SETTING

Multicenter IVF practice.

PATIENT(S): Couples qualifying for publicly funded IVF treatment under New Zealand's Clinical Priority Assessment Criteria. Couples (n = 974) started treatment between July 2011 and June 2013, used their own gametes, and were eligible for up to 2 IVF packages of funded care (including the transfer of surplus embryos).

INTERVENTION(S): None.

MAIN OUTCOME MEASURE(S): IVF dropout rate, reason for dropout, and cumulative live birth rate.

RESULT(S): A low IVF dropout rate between the first and second IVF cycle was reported within this controlled IVF population, with 10% of couples discontinuing treatment for reasons related to stress. The cumulative live birth rate in this "low dropout" population was 59% at the end of treatment, ranging from 72% (≤30 years) to 42% (38-39 years) according to female age. Most patients who discontinued for stress had a good prognosis, and a third of patients still had embryos in cryostorage. Only 30% of those who discontinued used the funded counseling services.

CONCLUSION(S): A low dropout rate (10%) can be achieved within an actively managed IVF population. This was lower than previously reported, suggesting that prognosis, cost, and treatment management are the significant causes of dropout within the general IVF population. Couples with many embryos also require psychological support because of treatment fatigue or repeated transfers.

摘要

目的

在新西兰一个有资金支持并积极管理的护理体系中,从一个受控制的人群中确定第一次和第二次体外受精(IVF)周期之间的脱落率,包括脱落的原因和相关的累积活产率。

设计

回顾性队列研究。

设置

多中心 IVF 实践。

患者

符合新西兰临床优先评估标准的有资格接受公共资助 IVF 治疗的夫妇。夫妇(n=974)于 2011 年 7 月至 2013 年 6 月期间开始治疗,使用自己的配子,有资格获得最多 2 个 IVF 套餐的资助护理(包括剩余胚胎的转移)。

干预

无。

主要观察指标

IVF 脱落率、脱落原因和累积活产率。

结果

在这个受控制的 IVF 人群中,第一次和第二次 IVF 周期之间报告了较低的 IVF 脱落率,10%的夫妇因与压力相关的原因停止治疗。在这个“低脱落”人群中,治疗结束时的累积活产率为 59%,根据女性年龄,范围从 72%(≤30 岁)到 42%(38-39 岁)。大多数因压力而停止治疗的患者预后良好,三分之一的患者仍有冷冻胚胎。只有 30%的停止治疗的患者使用了资助的咨询服务。

结论

在积极管理的 IVF 人群中,可以实现较低的脱落率(10%)。这低于之前的报告,表明在一般 IVF 人群中,预后、成本和治疗管理是脱落的主要原因。由于治疗疲劳或反复移植,拥有许多胚胎的夫妇也需要心理支持。

相似文献

1
Dropout rate and cumulative birth outcomes in couples undergoing in vitro fertilization within a funded and actively managed system of care in New Zealand.在新西兰一个有资金支持和积极管理的护理体系中,接受体外受精的夫妇的辍学率和累计生育结局。
Fertil Steril. 2021 Jul;116(1):114-122. doi: 10.1016/j.fertnstert.2021.01.041. Epub 2021 Mar 19.
2
ICSI does not increase the cumulative live birth rate in non-male factor infertility.ICSI 并不会增加非男性因素不孕的累积活产率。
Hum Reprod. 2018 Jul 1;33(7):1322-1330. doi: 10.1093/humrep/dey118.
3
Management of the first in vitro fertilization cycle for unexplained infertility: a cost-effectiveness analysis of split in vitro fertilization-intracytoplasmic sperm injection.不明原因不孕患者首次体外受精周期的管理:体外受精-胞浆内单精子注射拆分的成本效益分析。
Fertil Steril. 2013 Nov;100(5):1381-8. doi: 10.1016/j.fertnstert.2013.06.035. Epub 2013 Jul 19.
4
Predicting personalized cumulative live birth following in vitro fertilization.预测体外受精后的个性化累积活产情况。
Fertil Steril. 2022 Feb;117(2):326-338. doi: 10.1016/j.fertnstert.2021.09.015. Epub 2021 Oct 19.
5
Cost-effectiveness of 'immediate IVF' versus 'delayed IVF': a prospective study.“即刻体外受精”与“延迟体外受精”的成本效益:一项前瞻性研究。
Hum Reprod. 2017 May 1;32(5):999-1008. doi: 10.1093/humrep/dex018.
6
Cumulative live birth rates following blastocyst- versus cleavage-stage embryo transfer in the first complete cycle of IVF: a population-based retrospective cohort study.囊胚期胚胎与卵裂期胚胎移植在体外受精第一周期中的累积活产率:基于人群的回顾性队列研究。
Hum Reprod. 2020 Oct 1;35(10):2365-2374. doi: 10.1093/humrep/deaa186.
7
Factors influencing the cumulative conception rate and discontinuation of in vitro fertilization treatment for infertility.影响不孕症体外受精治疗累积受孕率及终止治疗的因素。
Fertil Steril. 2002 Jul;78(1):40-6. doi: 10.1016/s0015-0282(02)03160-6.
8
Cumulative live birth rates for women returning to ART treatment for a second ART-conceived child.女性因第二个接受 ART 受孕的孩子而返回接受 ART 治疗的累积活产率。
Hum Reprod. 2020 Jun 1;35(6):1432-1440. doi: 10.1093/humrep/deaa030.
9
Which factors are most predictive for live birth after in vitro fertilization and intracytoplasmic sperm injection (IVF/ICSI) treatments? Analysis of 100 prospectively recorded variables in 8,400 IVF/ICSI single-embryo transfers.在体外受精和卵胞浆内单精子注射(IVF/ICSI)治疗后,哪些因素对活产的预测性最强?对8400例IVF/ICSI单胚胎移植中100个前瞻性记录变量的分析。
Fertil Steril. 2017 Mar;107(3):641-648.e2. doi: 10.1016/j.fertnstert.2016.12.005. Epub 2017 Jan 17.
10
Factors influencing the clinical outcome of preimplantation genetic testing for polycystic kidney disease.影响多囊肾病胚胎植入前遗传学检测临床结局的因素。
Hum Reprod. 2019 May 1;34(5):949-958. doi: 10.1093/humrep/dez027.

引用本文的文献

1
The difference in patient-centered medical experiences between public fertility care and private fertility care in China: a multicenter cross-sectional study.中国公立与私立生育医疗服务中以患者为中心的就医体验差异:一项多中心横断面研究
BMC Public Health. 2025 May 21;25(1):1874. doi: 10.1186/s12889-025-22893-z.
2
Association of state insurance coverage mandates with assisted reproductive technology care discontinuation.州保险覆盖范围要求与辅助生殖技术护理的终止有关。
Am J Obstet Gynecol. 2023 Mar;228(3):315.e1-315.e14. doi: 10.1016/j.ajog.2022.10.046. Epub 2022 Nov 9.
3
Development, implementation and initial feasibility testing of the MediEmo mobile application to provide support during medically assisted reproduction.
开发、实施和初步可行性测试 MediEmo 移动应用程序,以在医学辅助生殖过程中提供支持。
Hum Reprod. 2022 May 3;37(5):1007-1017. doi: 10.1093/humrep/deac046.